88 related articles for article (PubMed ID: 6313033)
1. Dust exposure and mortality in an American factory using chrysotile, amosite, and crocidolite in mainly textile manufacture.
McDonald AD; Fry JS; Woolley AJ; McDonald JC
Br J Ind Med; 1983 Nov; 40(4):368-74. PubMed ID: 6313033
[TBL] [Abstract][Full Text] [Related]
2. Follow-up study of chrysotile textile workers: cohort mortality and exposure-response.
Hein MJ; Stayner LT; Lehman E; Dement JM
Occup Environ Med; 2007 Sep; 64(9):616-25. PubMed ID: 17449563
[TBL] [Abstract][Full Text] [Related]
3. An updated evaluation of reported no-observed adverse effect levels for chrysotile, amosite, and crocidolite asbestos for lung cancer and mesothelioma.
Beckett EM; Abelmann A; Roberts B; Lewis RC; Cheatham D; Miller EW; Hall E; Pierce JS
Crit Rev Toxicol; 2023 Nov; 53(10):611-657. PubMed ID: 38126124
[TBL] [Abstract][Full Text] [Related]
4. Quantitative relationships of exposure to chrysotile asbestos and mesothelioma mortality.
Loomis D; Richardson DB; Elliott L
Am J Ind Med; 2019 Jun; 62(6):471-477. PubMed ID: 31087402
[TBL] [Abstract][Full Text] [Related]
5. Cancer mortality in chrysotile miners and millers, Russian Federation: main results (Asbest Chrysotile Cohort-Study).
Schüz J; Kovalevskiy E; Olsson A; Moissonnier M; Ostroumova E; Ferro G; Feletto E; Schonfeld SJ; Byrnes G; Tskhomariia I; Straif K; Morozova T; Kromhout H; Bukhtiyarov I
J Natl Cancer Inst; 2024 Jun; 116(6):866-875. PubMed ID: 38247448
[TBL] [Abstract][Full Text] [Related]
6. The presence of erionite in North American geologies and the estimated mesothelioma potency by region.
Stevens ME; Paustenbach DJ; Lockhart NJ; Busboom DE; Deckard BM; Brew DW
Inhal Toxicol; 2024 Mar; 36(3):158-173. PubMed ID: 38583132
[TBL] [Abstract][Full Text] [Related]
7. Estimating the asbestos-related lung cancer burden from mesothelioma mortality.
McCormack V; Peto J; Byrnes G; Straif K; Boffetta P
Br J Cancer; 2012 Jan; 106(3):575-84. PubMed ID: 22233924
[TBL] [Abstract][Full Text] [Related]
8. UK asbestos imports and mortality due to idiopathic pulmonary fibrosis.
Barber CM; Wiggans RE; Young C; Fishwick D
Occup Med (Lond); 2016 Mar; 66(2):106-11. PubMed ID: 26511746
[TBL] [Abstract][Full Text] [Related]
9. Malignant Mesothelioma Mortality - United States, 1999-2015.
Mazurek JM; Syamlal G; Wood JM; Hendricks SA; Weston A
MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(8):214-218. PubMed ID: 28253224
[TBL] [Abstract][Full Text] [Related]
10. Asbestos surface provides a niche for oxidative modification.
Nagai H; Ishihara T; Lee WH; Ohara H; Okazaki Y; Okawa K; Toyokuni S
Cancer Sci; 2011 Dec; 102(12):2118-25. PubMed ID: 21895868
[TBL] [Abstract][Full Text] [Related]
11. Estimating the effect of cumulative occupational asbestos exposure on time to lung cancer mortality: using structural nested failure-time models to account for healthy-worker survivor bias.
Naimi AI; Cole SR; Hudgens MG; Richardson DB
Epidemiology; 2014 Mar; 25(2):246-54. PubMed ID: 24487207
[TBL] [Abstract][Full Text] [Related]
12. A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.
Visonà SD; Bertoglio B; Favaron C; Capella S; Belluso E; Colosio C; Villani S; Ivic-Pavlicic T; Taioli E
J Transl Med; 2023 Dec; 21(1):875. PubMed ID: 38041166
[TBL] [Abstract][Full Text] [Related]
13. Dust diseases and the legacy of corporate manipulation of science and law.
Egilman D; Bird T; Lee C
Int J Occup Environ Health; 2014; 20(2):115-25. PubMed ID: 24999846
[TBL] [Abstract][Full Text] [Related]
14. Asbestos: use, bans and disease burden in Europe.
Kameda T; Takahashi K; Kim R; Jiang Y; Movahed M; Park EK; Rantanen J
Bull World Health Organ; 2014 Nov; 92(11):790-7. PubMed ID: 25378740
[TBL] [Abstract][Full Text] [Related]
15. Developing a company-specific job exposure matrix for the Asbest Chrysotile Cohort Study.
Feletto E; Kovalevskiy EV; Schonfeld SJ; Moissonnier M; Olsson A; Kashanskiy SV; Ostroumova E; Bukhtiyarov IV; Schüz J; Kromhout H
Occup Environ Med; 2022 May; 79(5):339-346. PubMed ID: 34625507
[TBL] [Abstract][Full Text] [Related]
16. Reconstructing historical exposure to asbestos: the validation of 'educated guesses'.
Visonà SD; Crespi E; Belluso E; Capella S; De Matteis S; Filippi F; Lai M; Loscerbo R; Meloni F; Pilia I; Cocco P; Colosio C
Occup Med (Lond); 2022 Dec; 72(8):534-540. PubMed ID: 35943161
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary fibrosis following household exposure to asbestos dust?
Schneider J; Brückel B; Fink L; Woitowitz HJ
J Occup Med Toxicol; 2014; 9(1):39. PubMed ID: 25419224
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment of gastric cancer associated with asbestosis: a case report.
Park SH; Kang DM; Koo BH; Kim YK; Kim JE
Ann Occup Environ Med; 2015; 27():9. PubMed ID: 25908993
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenicity of fibrous glaucophane: How should we fill the data gaps?
Wylie AG; Korchevskiy AA
Curr Res Toxicol; 2021; 2():202-203. PubMed ID: 34345861
[TBL] [Abstract][Full Text] [Related]
20. Adverse health effects of asbestos: solving mysteries regarding asbestos carcinogenicity based on follow-up survey of a Chinese factory.
Yano E
Environ Health Prev Med; 2018 Aug; 23(1):35. PubMed ID: 30089452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
